ArticleThe Pan African medical journal2026
Factors associated with outbreak of diphtheria in Kafanchan, Kaduna State, Nigeria: July-October 2023.
Article in The Pan African medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The year 2023 witnessed the re-emergence of diphtheria in Nigeria. Kafanchan, Kaduna State, reported an unusual surge in cases and deaths. We investigated the outbreak to identify associated risk factors of the disease. We conducted an unmatched (1:2) case-control study. Case-patients were identified through the State linelist and traced to their residence. At the same time, controls were randomly selected from neighbors without symptoms or signs suggestive of diphtheria within the same community. Data was collected using an interviewer-administered structured questionnaire. Bivariate analysis was done to ascertain the odds ratio (OR), while multivariate logistic regression analysis was done to calculate the adjusted odds ratio (aOR). The confidence interval (CI) was set at 95%. A total of 91 case-patients and 182 controls were recruited. The median age of case-patients was 7 years (5-10 years). Forty (44%) of 91 case-patients were females. Sixty-four (70%) of 91 case-patients were from Kafanchan ward B, and the case fatality rate was 23%. Exposure to pentavalent vaccination was found to be associated with protection from diphtheria (aOR: 0.39, 95% CI: 0.20-0.77). Thirty-one (34.07%) of 91 case-patients had contact with someone with respiratory symptoms [OR = 37.2; 95% CI = 16.8-82.6; p <0.001]. Thirty-seven (40.66%) of 91 case-patients had contact with a confirmed case [OR = 25.1; 95% CI = 11.7-53.8; p < 0.001]. Twenty-three (25%) of 91 case-patients had never received the pentavalent vaccine, and the primary reason cited by caregivers was that they were unaware of any benefits of vaccination. The outbreak is attributable to suboptimal pentavalent vaccination coverage. Future outbreaks may be avoided or their impact reduced through improved risk communication and community engagement on the benefits of vaccination, strengthening routine immunization services, early warning surveillance, and prepositioning of diphtheria antitoxin (DAT) and antibiotics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.